Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

544.52
+2.830.52%
Pre-market: 543.61-0.9100-0.17%08:26 EDT
Volume:1.20M
Turnover:651.17M
Market Cap:138.15B
PE:31.69
High:546.84
Open:535.38
Low:532.23
Close:541.69
52wk High:555.69
52wk Low:374.17
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.46
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.82
PE(LYR):35.54

Loading ...

Vertex to Buy Crinetics for $10 Billion in Rare-Diseases Push

Reuters
·
Jul 07

Vertex Minerals Launches $0.10 Share Purchase Plan for Existing Investors

TIPRANKS
·
Jul 07

PRESS Digest -wall Street Journal - July 7

Reuters
·
Jul 07

Crinetics downgraded to Neutral from Overweight at Cantor Fitzgerald

TIPRANKS
·
Jul 07

Dow Jones Top Company Headlines at 9 PM ET: Samsung Expects Another Record Quarter on Robust AI Chip Demand | Walmart ...

Dow Jones
·
Jul 07

Vertex to Acquire Crinetics in $10 Billion Merger

TIPRANKS
·
Jul 07

M&A News: Vertex Stock (VRTX) Slips After Announcing $10B Crinetics Acquisition

TIPRANKS
·
Jul 07

Crinetics Pharmaceuticals - Co May Pay Termination Fee of $350.47 Mln to Vertex if Deal is Terminated Under Certain Circumstances - SEC Filing

THOMSON REUTERS
·
Jul 07

Crinetics Shares More than Doubles in After Market Trade After Vertex Announces $10 Billion Acquisition Deal, Last up 101% at $84.80

THOMSON REUTERS
·
Jul 07

Vertex EVP, Chief Legal Officer Joy Liu Sells 828 Vertex Shares Worth $416,243.88

Reuters
·
Jul 07

Vertex to acquire Crinetics for $85 per share in cash

TIPRANKS
·
Jul 07

Vertex to Buy Crinetics for USD 85 Per Share in USD 10 Billion Deal

Reuters
·
Jul 07

Crinetics Pharmaceuticals: Financing Supported by $4.5 Bln of Fully Committed Bridge Financing from Bank of America, Morgan Stanley Senior Funding

THOMSON REUTERS
·
Jul 07

Crinetics Pharmaceuticals: Deal Expected to be Accretive Vertex's to Non-gaap Operating Income in 2029

THOMSON REUTERS
·
Jul 07

Crinetics Pharmaceuticals Inc: Vertex Will Acquire Crinetics for $85.00 Per Share in Cash

THOMSON REUTERS
·
Jul 07

Vertex Signs LOI with Pcpa for Alyftrek in Cystic Fibrosis Treatment

Reuters
·
Jul 06

Vertex Signs Letter of Intent for Cystic Fibrosis Therapy in Canada

MT Newswires Live
·
Jul 06

Vertex enters LOI with pan-Canadian Pharmaceutical Alliance for ALYFTREK

TIPRANKS
·
Jul 06

Vertex Pharmaceuticals - to Initiate Discussions for Public Listing of Alyftrek in Canada

THOMSON REUTERS
·
Jul 06

Vertex Signs Letter of Intent (loi) with the Pan-canadian Pharmaceutical Alliance for Alyftrek for the Treatment of Cystic Fibrosis

THOMSON REUTERS
·
Jul 06